Vanta Bioscience Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|
| Revenue | 2.37 | 1.71 | TBA |
| Operating Expense | 2.88 | 1.38 | TBA |
| Net Profit | -1.22 | -1.51 | TBA |
| Net Profit Margin | -51.48 | -88.30 | TBA |
| Earning Per Share | TBA | -2.39 | TBA |
| EBIDTA | -0.51 | 0.31 | TBA |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2023 |
|---|---|
| Revenue | 2.37 |
| Operating Expense | 2.88 |
| Net Profit | -1.22 |
| Net Profit Margin | -51.48 |
| Earning Per Share | TBA |
| EBIDTA | -0.51 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 8.56 | 5.17 | 9.35 |
| Operating Expenses Annual | 4.91 | 5.65 | 5.95 |
| Operating Profit Annual | 3.70 | 0.15 | 3.57 |
| Interest Annual | 2.42 | 3.11 | 2.11 |
| Depreciation | 1.24 | 1.25 | 1.32 |
| Net Profit Annual | 0.05 | -4.24 | 0.08 |
| Tax Annual | -0.01 | 0.03 | 0.06 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 8.56 |
| Operating Expenses Annual | 4.91 |
| Operating Profit Annual | 3.70 |
| Interest Annual | 2.42 |
| Depreciation | 1.24 |
| Net Profit Annual | 0.05 |
| Tax Annual | -0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.07 | 0.07 | 0.07 |
| Cash Flow from Operations | 4.55 | 0.64 | 6.70 |
| Cash Flow from Investing | -1.67 | -2.53 | -8.08 |
| Cash Flow from Financing | -2.81 | 1.88 | 1.38 |
| Cash Flow at the End | 0.14 | 0.07 | 0.07 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.07 |
| Cash Flow from Operations | 4.55 |
| Cash Flow from Investing | -1.67 |
| Cash Flow from Financing | -2.81 |
| Cash Flow at the End | 0.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 42.76 | 2.90 | 38.18 |
| PBIT Margin (%) | 28.27 | -21.28 | 24.06 |
| PBT Margin (%) | 16.59 | -14.51 | 12.62 |
| Net PROFIT Margin (%) | 0.58 | -82.01 | 0.86 |
| Return On Networth / Equity (%) | 0.05 | TBA | 0.33 |
| Return On Networth /Employed (%) | 5.24 | TBA | 5.24 |
| Return On Assets (%) | 0.11 | -9.02 | 0.19 |
| Total Debt / Equity (X) | 1.29 | 1.06 | 0.79 |
| Asset Turnover Ratio (%) | 0.19 | 0.11 | 0.22 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 42.76 |
| PBIT Margin (%) | 28.27 |
| PBT Margin (%) | 16.59 |
| Net PROFIT Margin (%) | 0.58 |
| Return On Networth / Equity (%) | 0.05 |
| Return On Networth /Employed (%) | 5.24 |
| Return On Assets (%) | 0.11 |
| Total Debt / Equity (X) | 1.29 |
| Asset Turnover Ratio (%) | 0.19 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 37.87 | 37.40 | 36.12 |
| Total Current Assets Annual | 12.03 | 11.13 | 11.00 |
| Non Current Assets Annual | 40.88 | 40.51 | 39.40 |
| Total Shareholders Funds Annual | 19.79 | 19.74 | 23.99 |
| Total Assets Annual | 52.91 | 51.64 | 50.40 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 37.87 |
| Total Current Assets Annual | 12.03 |
| Non Current Assets Annual | 40.88 |
| Total Shareholders Funds Annual | 19.79 |
| Total Assets Annual | 52.91 |
EPS (INR)
Expected
0.00
Reported
-4.06
Surprise
0.00%
Dec 2021
EPS beaten by 0.00%
